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ABSTRACT
Aim: In patients with oral cancer, the head and neck 
and lung fields are often evaluated by several imaging 
examinations. Among the imaging examinations other 
than fluorodeoxyglucose positron emission tomog-
raphy/computed tomography （FDG-PET/CT）, whole-
body evaluation, including the lower abdomen and 
below is rarely performed routinely as a preoperative 
examination for oral cancer. However, a patient with 
oral cancer may also have potentially an abdominal 
disease, and early detection is required particularly in 
a fatal disease. This report discusses the importance of 
FDG-PET/CT for preoperative whole-body screening 
and the pitfalls of preoperative evaluation for oral 
cancer.
Case presentation: This article describes a 65-year-
old man with an incidentally-detected abdominal aortic 
aneurysm at a site remote from the head and neck, on 
preoperative examination using FDG-PET/CT for oral 
squamous cell carcinoma. An abdominal aortic aneu-
rysm was detected incidentally on the unenhanced CT 
portion of the FDG-PET/CT. FDG did not accumulate 
in the abdominal aortic aneurysm; the abdominal 
aortic aneurysm was detected only on the unenhanced 
CT portion. Perioperative blood pressure was carefully 
controlled, and 2 weeks after the oral surgery, cardio-
vascular surgeons performed endovascular stent 
grafting for the abdominal aortic aneurysm.
Conclusions: With FDG-PET/CT examination results, 
it is important to properly confirm not only FDG 
accumulation but also the unenhanced CT portion, and 
it is necessary to consider the possibility that a fatal 
abdominal disease may be detected by a whole-body 
evaluation for oral cancer.
1. Introduction
 18F-fluorodeoxyglucose positron emission tomog-
raphy/computed tomography （FDG-PET/CT） is a 
valuable imaging examination for diagnosis, staging, 
and treatment in all areas of clinical oncology, 
including oral cancer, and head and neck cancer 1）, 2）. 
FDG-PET/CT permits evaluating the entire body as 
well as the local region of the primary tumor 3）. This 
article describes a case of oral squamous cell carci-
noma （OSCC） in a 65-year-old man with an inciden-
tally-detected abdominal aortic aneurysm （AAA） on 




 A 65-year-old man was referred to our outpatient 
office for further evaluation of a mass on the oral floor. 
He had a medical history of hypertension, and was 
taking antihypertensive medications （candesartan 
cilexetil and amlodipine besilate） orally. He had 
smoked approximately 1–2 packs of cigarettes per day 
for over 40 years. The first clinical examination 
revealed a white mucosal lesion with induration 
measuring 5 × 5 mm on the left oral floor （Figure 1）. 
Figure 1　 Clinical presentation, intraoral view （published 
with the patient’s consent）.
Figure 2　 Magnetic resonance image （short TI inversion recovery） showing a contrast-enhanced lesion. 
（A） Axial plane. （B） Sagittal plane.
The histopathological diagnosis of OSCC was made by 
biopsy. We performed imaging evaluations for the 
primary lesion and for the lung fields, as the most 
frequent sites of distant metastasis of OSCC. We 
performed plain chest radiography, contrast-enhanced 
CT （CECT）, magnetic resonance imaging （MRI）, and 
FDG-PET/CT. The imaging range of the CECT was 
from the head and neck to the upper lung fields, and 
MRI was limited to the head and neck. The primary 
lesion was so small that it was only slightly visible on 
MRI （Figure 2）, and not at all visible on CECT or 
FDG-PET/CT. Plain chest radiography showed no 
evidence of an aneurysm （Figure 3）, and there was no 
finding suggesting distant metastases （Figure 4）. 
However, an AAA was detected incidentally on the 
unenhanced CT portion of the FDG-PET/CT （axial 
plane only）. The AAA measured 50 × 38 mm 
（Figure 5）, and FDG did not accumulate in the AAA 
（Figure 6）. We consulted a cardiovascular surgeon and 
planned to treat the AAA after the OSCC surgery. 
Because of the clinical diagnosis of stage 1 OSCC 
（cT1N0M0）, tumor resection was performed under 
general anesthesia （Figure 7）. Perioperative blood 
pressure was carefully controlled to not exceed 110 
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Figure 3　 Plain chest radiograph showing no evidence 
of an aneurysm.
Figure 4　 18F-fluorodeoxyglucose positron emission 
tomography image showing no findings 
suggesting distant metastases.
Figure 5　 An abdominal aortic aneurysm detected on the 
unenhanced computed tomography portion of 
18F-fluorodeoxyglucose positron emission 
tomography.
Figure 6　 18F-fluorodeoxyglucose did not accumulate in 
the abdominal aortic aneurysm.
Figure 7　 The histological features of the squamous cell 
carcinoma. （Hematoxylin and eosin staining, 
×20; scale bar, 100 µm）．
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mmHg, and 2 weeks after the oral surgery, cardiovas-
cular surgeons performed endovascular stent grafting 
for the AAA （Figure 8）. The patient’s postoperative 
course was uneventful （Figure 9）, and there was no 
evidence of complications.
3. Discussion
 Most AAAs are asymptomatic, and are often 
detected as an incidental finding in imaging evalua-
tions for other purposes4）, 5）. The main examinations 
that detect an AAA are abdominal ultrasonography, 
abdominal CT, and MRI performed for other abdominal 
diseases occurring in the same area as the AAA6）, 7）.
However, in head and neck cancer, which is a disease 
that occurs in a region completely apart from an AAA, 
it is difficult to detect an AAA by routine preoperative 
imaging examinations other than FDG-PET/CT.
 Because of staging of malignancies, which is one of 
the roles of FDG-PET/CT, a whole-body evaluation is 
usually performed. Therefore, FDG-PET/CT may 
detect another disease incidentally that requires addi-
tional inspection in other areas8）–11）. According to 
previous studies, lung diseases such as pulmonary 
nodules, pleural effusion, and pneumothorax are often 
detected8）, 9）. The main diseases for which FDG-PET/
CT is used to detect other diseases are malignant 
lymphoma and lung cancer, and the frequency of its 
use in head and neck cancer is low10）, 11）.
Figure 8　 Computed tomography angiography of the aorta. （A） Before the operation. （B） After endovascular stent 
grafting.
Figure 9　 Intraoral examination 6 months after the 
surgery.
65Incidental finding of an abdominal aortic aneurysm detected on the unenhanced CT portion of FDG-PET/CT for preoperative screening in a patient with oral squamous cell carcinoma（Shudo）
 Recently, it has been suggested that FDG-PET/CT 
could be valuable for evaluating aortic diseases such as 
aortic aneurysm, acute thoracic aortic syndromes, 
atherosclerotic lesions, aortitis, and aortic malignan-
cies12）–16）. Regarding aortic aneurysm, FDG accumula-
tion in an AAA may predict expansion and progression 
in symptomatic patients; however, in asymptomatic 
patients, FDG-PET/CT results vary widely and are 
inconsistent17）–20）. In our patient, the AAA was asymp-
tomatic and accumulated no FDG; the AAA was 
detected only on the unenhanced CT portion. With 
FDG-PET/CT examination results, it is important to 
properly confirm not only FDG accumulation but also 
the unenhanced CT portion.
 The United States Preventive Services Task Force 
recommends that men between the age of 65 and 75 
years who have ever smoked should be screened at 
least once for AAAs by abdominal ultrasonography21）. 
However, in patients with oral cancer, it is difficult to 
perform preoperative abdominal ultrasonography for all 
target patients. In our patient, the tumor was small; 
however, surgery under general anesthesia was 
planned after the diagnosis from the partial biopsy, 
and as a result, AAA was detected on preoperative 
screening. Considering that whole-body evaluation is 
not possible with routine imaging examinations for oral 
cancer other than with FDG-PET/CT, in the case of 
target patients, performing FDG-PET/CT may be 
recommended ,  even for early -stage cancer . 
Furthermore, it is necessary to consider the possibility 
that a fatal abdominal disease may be detected by a 
whole-body evaluation for oral cancer, and to obtain 
informed consent before imaging.
4. Conclusion
 With FDG-PET/CT examination results, it is 
important to properly confirm not only FDG accumula-
tion but also the unenhanced CT portion, and it is 
necessary to consider the possibility that a fatal 
abdominal disease may be detected by a whole-body 
evaluation for oral cancer. Identifying any incidental 
finding is crucial to provide appropriate care for the 
cancer patient and achieve a better outcome.
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